Loading...

Tag trends are in beta. Feedback? Thoughts? Email me at [email protected]

Treatment for osteoarthritis: messenger RNA (mRNA) that produces the protein responsible for anchoring the fibrous structure of cartilage.

Study of 51 adults receiving an mRNA COVID-19 vaccine found stronger interferon-related immune activity before vaccination predicted more pronounced temporary side effects, helping explain why some people experience stronger reactions than others.

Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma

mRNA immunotherapy eliminates pancreatic tumors in mice: Approximately 50% of mice with pancreatic cancer treated with the mRNA immunotherapeutic cocktail saw complete tumor responses and more impressively…

BioNTech halts mRNA colorectal cancer vaccine trial after safety review

Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial

FDA Approves First mRNA Flu Shot

The mRNA-LNP vaccine encoding viral VP2 confers effective protection against novel variant infectious bursal disease virus (nVarIBDV)

Global review confirms mRNA vaccines are safe, effective and full of promise 

New study advances dry mRNA vaccine microneedle patches that use hundreds of tiny tips to deliver vaccine into the skin as an alternative to traditional injections, a design that could help make future mRNA vaccines easier to store and distribute and reduce the need for cold-chain logistics.

FDA advisors unanimously vote to approve Moderna's mRNA after agency drama

Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo

A personalized mRNA cancer vaccine continued to reduce the risk of recurrence and distant spread in resected high-risk melanoma at five years of follow-up, according to updated results from a randomized phase 2b trial

In vivo reprogramming of cytotoxic effector CD8 T cells via fractalkine-conjugated mRNA-LNPs

mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models

A new approach to cancer vaccination yields more powerful T cells using mRNA vaccines

Moderna’s mRNA flu vaccine more effective than standard shot in late-stage trial

Training mRNA Language Models Across 25 Species for $165

Pancreatic cancer mRNA vaccine shows lasting results in an early trial

In a move that could revolutionize how acne is treated, Sanofi has launched early-stage clinical trials for an investigational mRNA acne vaccine, a first-of-its-kind approach that leverages the same technology used in COVID-19 vaccines.

Studies report that mRNA-based cancer vaccines are being evaluated in clinical trials for melanoma, showing ability to generate tumor-specific immune responses and support immunotherapy approaches in recent oncology research

New allergy immunotherapy for cross-reactive allergies (food and pollen) based on mRNA and consensus designed allergens

Johns Hopkins scientists engineer nanoparticles able to seek and destroy diseased immune cells: « Proof of principle study in mice uses emerging technology mRNA-based therapies

FDA reverses course on rejection of Moderna's mRNA flu vaccine

FDA declines to review Moderna's mRNA flu shot

FDA reverses course and will review Moderna's mRNA flu shot, company says

FDA refuses to review Moderna's mRNA flu vaccine

mRNA cancer vaccine shows protection at 5-year follow-up, Moderna and Merck say

Researchers found a method to reprogram macrophages inside solid tumors—the deadliest and most resistant cancers—using mRNA

MHRA approves self replicating mRNA Covid-19 vaccine

More →